Collegium Pharmaceutical (COLL) Market Capitalization (2015 - 2026)

Collegium Pharmaceutical has reported Market Capitalization for 12 years, with the latest figure at $1.2 billion in Q2 2026.

• On a quarterly basis, Market Capitalization rose 26.1% year-over-year to $1.2 billion in Q2 2026; TTM through Jun 2026 was $1.2 billion, a 26.1% increase from a year earlier, with the FY2025 full-year figure at $1.5 billion, up 62.98% from the prior year.
• Market Capitalization was $1.2 billion for Q2 2026 at Collegium Pharmaceutical, up from $1.1 billion in the prior quarter.
• The five-year high for Market Capitalization was $1.5 billion in Q4 2025, with the low at $541.1 million in Q3 2022.
• Average Market Capitalization over 5 years is $949.3 million, with a median of $946.0 million recorded in 2025.
• The sharpest annual moves came in 2022 and 2024: Market Capitalization slipped 28.03% in 2022, then surged 68.54% in 2024.
• Over 5 years, Market Capitalization stood at $785.3 million in 2022, then advanced by 24.91% to $980.9 million in 2023, then declined by 8.17% to $900.8 million in 2024, then surged by 62.98% to $1.5 billion in 2025, then retreated by 19.86% to $1.2 billion in 2026.
• The last three Market Capitalization figures came in at $1.2 billion (Q2 2026), $1.1 billion (Q1 2026), and $1.5 billion (Q4 2025), per Business Quant data.